PF-06342674

· Pfizer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PF-06342674, covering 2014-06-19 to 2018-08-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study To Assess The Safety Of PF-06342674 In Adults With Type 1 Diabetes [Phase 1]